Thermo Fisher nixes $12.7B Qiagen acquisition after shareholders opt out
August 13, 2020 at 09:24 AM EDT
The Waltham life sciences giant failed to convince enough shareholders of the German testing firm to sell despite hiking its offer by nearly 14% last month.
